The Medical Intensive Care Unit (MICU) at the All India Institute of Medical Sciences (AIIMS) Bhopal has triumphed over the lethal poison Aluminium Phosphide, traditionally associated with almost 100% mortality.

Over the last month, the dedicated team of doctors, nurses, and paramedical staff at AIIMS Bhopal MICU has defied the odds by successfully saving the lives of three out of five patients affected by Aluminium Phosphide Poisoning.

The key to this remarkable success lies in the early initiation of Continuous Renal Replacement Therapy (CRRT), a groundbreaking approach that has proven to be the linchpin in the battle against this deadly poison. The doctors at AIIMS MICU emphasize that the timely administration of CRRT has been a crucial factor contributing to the unprecedented success in treating Aluminium Phosphide Among the survivors are a 17-year-old female, a 20-year-old male, and a 44-year-old male, all of whom sought medical attention at AIIMS within 12 hours of ingesting the poison.

These patients presented with severe metabolic acidosis, marked by a pH level below 7.0 and the serum lactate levels in the range of 20mmol/L. The comprehensive treatment protocol employed by the AIIMS Bhopal MICU team included CRRT, high-dose vasopressors, ionotropes, anti-arrhythmic drugs, and vigilant monitoring of serum electrolytes.

This holistic and multidisciplinary approach underscores the commitment of the medical professionals at AIIMS Bhopal to ensuring the best possible outcomes for their patients.

Professor (Dr.) Ajai Singh, Executive Director of AIIMS Bhopal, extended his heartfelt congratulations to the tireless team for their hard work and unwavering efforts. Dr. Singh emphasized the significance of this accomplishment, stating, "The success in treating Aluminium Phosphide poisoning is a testament to the dedication and expertise of our medical team. This breakthrough highlights the importance of innovative medical interventions in critical situations."